A seasoned management team
with long term commitment
We have the expertise to bridge the gap between fundamental science and patient access and needs.
Teun Grooters
CEO & Founder
Pharmaceutical executive with > 30 years highly successful track record
in various national and international management functions in companies such as BMS, Merck & Co, Wellcome, Yamanouchi, Grunenthal, Philips and Teva. Was founder and CEO of start-ups. Trained as a medical doctor, Teun’s experience spans General Management, International Business Unit Management, Clinical Development, Specialty Medicine, Generics and OTC. Consistently builds high performing teams that outperform the market.
Mark Thomson
CFO & Founder
Senior Finance professional, FCCA qualified with a broad experience in
Corporate, Finance, Sales & Marketing and Supply Chain positions. 17
years experience in the pharmaceuticals industry with Teva. Mark has a
proven track record of sound decision making and commercial achievements, proven in strong leadership and progressive people management skills, motivating and developing high performance.
Wendy van Overveld
Chief Commercial Officer
Experienced strategic marketeer with 27 years of experience in national and international strategic marketing, medical and business unit management positions. Has 6 years of international
experience as European & Global Brand Lead leading the global brand strategy in a highly competitive therapeutic area (CNS) for strategic drug launches. Wendy’s key areas of expertise are CNS, Oncology, Hematology and Drug repurposing. She has a strong patient centric focus and is proven competent in leading high performing matrix teams.
Marty Groen in ‘t Woud
Chief Business Officer
A pharmaceutical business professional with 30+ years of experience in global and regional market and business development, in- & out licensing and launch strategies in US and EMEA-regions in senior positions in companies such as Basf Pharma, Rhône-Poulenc-Rorer, Organon, Astellas and Teva. Marty’s key areas of expertise are Cardiovascular, Neurology, Dermatology, Pain and Urology. Marty is proven competent in leading multi-national and -disciplinary teams.
Frank Verbeeck
Chief Medical Officer
A qualified physician – clinical pathologist combining hospital management expertise with 22+ years of experience in the management
of global and European departments covering medical affairs and clinical development (Bristol Myers Squibb, Novartis, Astellas, Galapagos). Experience in building and designing organizational structures and governance bodies within clinical development and medical affairs. Board member of a global contract research organization.
Marta Andreykiv
SVP, Market access
Pricing and Market Access professional with 15 years of experience in consulting
and pharmaceutical industry. Strategic pricing expertise as well as Market Access throughout the product lifecycle (payer relevant input into clinical program, Health Economics and Outcomes Research, Cost-effectiveness modelling, Budget Impact analysis, HTA and EMA Scientific Advice, Health
Technology Assessment, Value communication, Real world evidence, Healthcare policy etc). Held Market Access management positions being based both in Europe and US. Previously Global Head of Market Access at Teva Pharmaceuticals.